Senti Biosciences Holdings (SNTI) Return on Sales [ROS] (2021 - 2026)
Senti Biosciences Holdings (SNTI) reported Return on Sales [ROS] of -85229.41% for Q2 2026.
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Senti Biosciences Holdings' Return on Sales [ROS] came in at -393358.82%; for FY2025, it came in at -312631.82%.
- Return on Sales [ROS] has a four-year change of -311166.91 percentage points (FY2021 to FY2025).
- By year, Return on Sales [ROS] came in at -3620.73% in FY2023 (-2172.20 pp), -1448.53% in FY2022 (+16.37 pp) and -1464.90% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] in data going back to Q2 2021.
- The high point for year-over-year Return on Sales [ROS] in five years was Q4 2023 (a gain of 24843.71 percentage points); the low point was Q4 2022 (a drop of 27091.77 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Senti Biosciences Holdings | 4.36 Mn | -39.74 Mn | - | -85,229.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85,229.41% |
| Mar 31, 2026 | -28,850.00% |
| Dec 31, 2025 | -19,212.37% |
| Sep 30, 2025 | -10,209.64% |
| Jun 30, 2024 | -27,287.28% |
| Mar 31, 2024 | -7,377.49% |
| Dec 31, 2023 | -3,620.70% |
| Sep 30, 2023 | -12,981.07% |
| Jun 30, 2023 | -1,620.92% |
| Mar 31, 2023 | -1,163.61% |
| Dec 31, 2022 | -28,464.41% |
| Sep 30, 2022 | -835.11% |
| Jun 30, 2022 | -1,603.17% |
| Mar 31, 2022 | -1,065.04% |
| Dec 31, 2021 | -1,372.64% |
| Sep 30, 2021 | -1,035.63% |
| Jun 30, 2021 | -1,134.43% |
API Access
Senti Biosciences Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SNTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();